Frederick T. Muto, Director at ISIS PHARMACEUTICALS INC (ISIS), sold 10,000 shares at $21.96 ($220K) on 2013-05-30, disclosed to the SEC on 2013-05-31.
Scheduled sale ($220k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IONS | SELL | 2019-05-08 | $582K | — | Filing → |
| IONS | SELL | 2018-05-31 | $697K | — | Filing → |
| IONS | SELL | 2017-06-02 | $565K | — | Filing → |